Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Blunt

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Oncotarget|July 17, 2024
Strategies to disrupt NKG2A:HLA-E interactions for improved anti-cancer immunityJack G Fisher, Lara V Graham, Matthew D Blunt
Biomedicines|August 29, 2024
NK Cells in the Lymph Nodes and Their Role in Anti-Tumour ImmunityLara V Graham, Salim I Khakoo, Matthew D Blunt
Pharmacological Reviews|October 2, 2012
Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignanciesJohn G Foster, Matthew D Blunt, Edward Carter, et al.
Journal of Translational Genetics and Genomics|January 17, 2024
Targeting KIR as a novel approach to improve CAR-NK cell functionLara V Graham, Jack G Fisher, Salim I Khakoo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2017
Hydrogen Peroxide Triggers a Dual Signaling Axis To Selectively Suppress Activated Human T Lymphocyte MigrationJennifer A Ball, Isabella Vlisidou, Matthew D Blunt, et al.
Vaccines|December 23, 2022
Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against CancerJack G Fisher, Amber D P Doyle, Lara V Graham, et al.
Exploration of Targeted Anti-Tumor Therapy|April 28, 2025
Modulation of anti-tumour immunity by XPO1 inhibitorsJack G Fisher, Laura G Bartlett, Trinayan Kashyap, et al.
HLA|November 2, 2018
A novel antibody combination to identify KIR2DS2<sup>high</sup> natural killer cells in KIR2DL3/L2/S2 heterozygous donorsMatthew D Blunt, Pauline Rettman, Leidy Y Bastidas-Legarda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 16, 2011
Evidence that the lipid phosphatase SHIP-1 regulates T lymphocyte morphology and motilityStephanie J Harris, Richard V Parry, John G Foster, et al.
Frontiers in Immunology|December 6, 2019
Constitutive Activation of Natural Killer Cells in Primary Biliary CholangitisTheresa J Hydes, Matthew D Blunt, Jennifer Naftel, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Oncotarget|July 17, 2024
Strategies to disrupt NKG2A:HLA-E interactions for improved anti-cancer immunityJack G Fisher, Lara V Graham, Matthew D Blunt
Biomedicines|August 29, 2024
NK Cells in the Lymph Nodes and Their Role in Anti-Tumour ImmunityLara V Graham, Salim I Khakoo, Matthew D Blunt
Pharmacological Reviews|October 2, 2012
Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignanciesJohn G Foster, Matthew D Blunt, Edward Carter, et al.
Journal of Translational Genetics and Genomics|January 17, 2024
Targeting KIR as a novel approach to improve CAR-NK cell functionLara V Graham, Jack G Fisher, Salim I Khakoo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2017
Hydrogen Peroxide Triggers a Dual Signaling Axis To Selectively Suppress Activated Human T Lymphocyte MigrationJennifer A Ball, Isabella Vlisidou, Matthew D Blunt, et al.
Vaccines|December 23, 2022
Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against CancerJack G Fisher, Amber D P Doyle, Lara V Graham, et al.
Exploration of Targeted Anti-Tumor Therapy|April 28, 2025
Modulation of anti-tumour immunity by XPO1 inhibitorsJack G Fisher, Laura G Bartlett, Trinayan Kashyap, et al.
HLA|November 2, 2018
A novel antibody combination to identify KIR2DS2<sup>high</sup> natural killer cells in KIR2DL3/L2/S2 heterozygous donorsMatthew D Blunt, Pauline Rettman, Leidy Y Bastidas-Legarda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 16, 2011
Evidence that the lipid phosphatase SHIP-1 regulates T lymphocyte morphology and motilityStephanie J Harris, Richard V Parry, John G Foster, et al.
Frontiers in Immunology|December 6, 2019
Constitutive Activation of Natural Killer Cells in Primary Biliary CholangitisTheresa J Hydes, Matthew D Blunt, Jennifer Naftel, et al.
Pageof 4